Eye drops made from pig semen deliver cancer treatment to mice
-
-
Bluesky
-
-
-
-
-
X
The retina is hard to penetrate with drugs because it has a protective barrier.Credit: Paul Whitten/Science Photo Library
Scientists have used pig semen to develop eye drops that can stop tumour growth in the retina and preserve vision, a study1 in mice shows. The work is published today in Science Advances.
It is hoped that the drops could be developed to treat children with retinoblastoma, a cancer of the retina. The condition is typically treated with injections of drugs into the eye, chemotherapy or laser therapy, all of which can damage non-cancerous parts of the eye. Yu Zhang and colleagues at Shenyang Pharmaceutical University in China wanted to develop a method that could penetrate the barrier around the retina and deliver the drugs without causing any unnecessary damage.
The eye drops contain exosomes — tiny particles released by almost every type of cell — engineered to carry molecules that kill cancer cells. Mice treated with the eye drops showed signs that the tumours had stopped growing. They also had comparable eyesight to control animals without tumours.
The team showed that it was possible for exosomes to penetrate the retina. The technique could improve drug delivery across other barriers that are similarly difficult to breach, such as the blood–brain barrier — to treat conditions including Alzheimer’s disease — or the mucosal barrier, says Chunxia Zhao, a researcher studying drug delivery and nanomedicine at Adelaide University in Australia.
Crossing barriers
The team used exosomes derived from semen because the particles enable sperm to penetrate the female reproductive tract. In studies with human corneal cells, the researchers determined that the exosomes from pig semen can open and close tight junctions — semipermeable structures found in the external membrane of the cells on the surface of the eye.
The researchers loaded the exosomes with a ‘nanozyme system’, containing carbon dots, manganese dioxide and glucose oxidase, to attack the cancer. When applied to the eye, the exosomes selectively penetrated tumour cells, and the nanozyme system then triggered their destruction. To improve the exosomes’ selectivity, the team attached them to folic acid molecules. Retinoblastoma cells have much higher levels of folic acid than healthy cells do.
When the researchers tested the drops in mice with retinal tumours, they observed that, 30 days later, the tumours remained small and the mice still had healthy eyesight. Among mice given eye drops containing components of the nanozyme system that were not packaged in exosomes, the tumours continued to grow — and spread to other parts of the eye — because the components could not penetrate the barrier around the eye.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
Access through your institution
or
Sign in or create an account
Continue with Google
Continue with ORCiD
doi: https://doi.org/10.1038/d41586-026-00982-2
References
- Zhao, J. et al. Sci. Adv. 12, eadw7275 (2026).
Article
Google Scholar
Download references
Reprints and permissions
Related Articles
-
Cheap blood test detects pancreatic cancer before it spreads
-
More than one-third of cancer cases are preventable, massive study finds
-
Alcohol and cancer risk: what you need to know
-
Cancer might protect against Alzheimer’s — this protein helps explain why
Subjects
-
Cancer
-
Brain
-
Medical research
Latest on:
-
Cancer
-
Brain
-
Medical research
-
Huge lung-cancer screening campaign boosts early diagnosis
Research Highlight 27 MAR 26
-
Androgen activity in the male embryonic hindbrain drives lethal PFA ependymoma
Article 25 MAR 26
-
Remembrance of inflammations past
News & Views 25 MAR 26
-
Charting the human brain’s lifelong functional organization
News & Views 25 MAR 26
-
First atlas of brain organization shows development over a lifetime
News 25 MAR 26
-
Brain’s protective barrier stays leaky for years after playing contact sports
News 18 MAR 26
-
Testosterone promotes growth of a type of brain tumour in young boys
News & Views 25 MAR 26
-
These medical X-rays are all deepfakes — and they fool even radiologists
News 24 MAR 26
-
Masked mitochondria slip into cells to treat disease in mice
News 19 MAR 26
Jobs
-
Research Scientist / Sr. Research Scientist or Postdoctoral Fellow
The DeKosky Laboratory at MIT and The Ragon Institute is hiring a computational researcher to advance computational drug design and discovery.
Cambridge, MA
DeKosky Laboratory at The Ragon Institute and MIT
-
Postdoctoral Fellow
A postdoctoral fellow position is available at NIH for translational research on neural mechanisms of frustration/irritability in mice and humans
Bethesda, Maryland (US)
Nat